March 20, 2026

Lawrence Blacher, M.D., Memorial Lecture: Advancing the Fight Against Cardiac Amyloidosis: A 2026 Update

Please join us to hear Omar F. Abou-Ezzeddine, M.D.C.M., M.S., at the Lawrence Blacher, M.D., Memorial Lecture, where he will provide a 2026 update on amyloid cardiomyopathy, highlighting current diagnostic strategies, emerging therapies, and practical approaches to patient care.

Baptist Health South Florida

March 17, 2026

2025 SABCS Highlights: Targeted Therapies for Advanced Breast Cancer

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the CAPItello-291, VIKTORIA-1, and STX-478 trials which were presented at the 2025 San Antonio Breast Cancer Symposium

Dana-Farber

March 13, 2026

Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference

Register for the Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 67th ASH Annual meeting, taking place on April 25-26 in Buffalo, NY.

Roswell Park Comprehensive Cancer Center

March 09, 2026

Newborn Vitamin K Refusal Trends

Investigators examine trends in newborn vitamin K refusal and associated neurologic outcomes.

Conexiant

March 05, 2026

How AI Is Ushering in a New Era in Cancer Care

On October 30, 2025, Google Cloud held its second annual Cancer AI Symposium to explore how artificial intelligence (AI) is advancing cancer research, diagnosis, and treatment, in unparalleled ways. H...

The ASCO Post

March 03, 2026

GLP-1 RAs in Chronic Migraine

Investigators evaluate health care utilization and treatment patterns vs topiramate in an active-comparator study.

Conexiant

March 01, 2026

Video: Early iDose TREX Data Show Double-Digit IOP Reduction

Steven R. Sarkisian Jr., MD, reviews early results with the iDose TREX extended-release travoprost implant.

Glaucoma Physician

March 01, 2026

Understanding FDA Pathways for MIGS

At AGS 2026, Douglas J. Rhee, MD, provided a practical overview of device regulation and its implications for MIGS adoption and reimbursement.

Glaucoma Physician

March 01, 2026

Video: Pegcetacoplan Data Show Increasing Benefit Over 5 Years

New data from the GALE study highlights the benefits of early pegcetacoplan treatment for geographic atrophy, showcasing significant retinal tissue preservation after five years.

Retinal Physician

March 01, 2026

Video: 3-Year Data Show Vision Gains With Optogenetic Therapy for RP

Positive outcomes from Nanoscope's MCO-010 trial for retinitis pigmentosa highlight a potential breakthrough in vision restoration, as showcased by Dr. Christine Nichols Kay at the 2026 Macula Society meeting.

Retinal Physician